C17 Globotriaosylceramide is a sphingolipid that has been used as an internal standard for the quantification of globotriaosylceramides in plasma and urine from patients with Fabry disease by GC-MS.

536745-81-0

C53H99NO18

1038.364

C17 Globotriaosylceramide (d18:1/17:0);C17 Globotriaosylceramide (d18:1/17:0)

DMSO:Soluble
Methanol:Warmed
Chloroform:Methanol (2:1):Soluble
Powder: -20°C for 3 years
In solvent: -80°C for 2 years